The anti-angiogenic peptide anginex greatly enhances Galectin-1 binding affinity for glycoproteins
Författare
Summary, in English
Angiogenesis is a key event in cancer progression and therefore a promising target in cancer treatment. Galectin-1, a β-galactoside binding lectin, is up-regulated in the endothelium of tumors of different origin and has been shown to be the target for anginex, a powerful anti-angiogenic peptide with anti-tumor activity. Here we show that when bound to anginex, galectin-1 binds various glycoproteins with hundred-to thousand-fold higher affinity. Anginex also interacts with galectin-2,-7,-8N, and-9N but not with galectin-3,-4, or-9C.
Avdelning/ar
- Avdelningen för mikrobiologi, immunologi och glykobiologi - MIG
- Centrum för analys och syntes
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2011
Språk
Engelska
Sidor
13801-13804
Publikation/Tidskrift/Serie
Journal of Biological Chemistry
Volym
286
Issue
16
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
American Society for Biochemistry and Molecular Biology
Ämne
- Immunology in the medical area
- Microbiology in the medical area
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1083-351X